• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle.促进肝癌的发展,通过介导细胞周期中的 DNA 复制。
Exp Biol Med (Maywood). 2022 Mar;247(5):395-408. doi: 10.1177/15353702211049149. Epub 2021 Nov 7.
2
Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.肿瘤组织中 BUB1B、CCNB1、CDC7、CDC20 和 MCM3 的上调预示着肝细胞癌患者总体生存和无病生存更差。
Biomed Res Int. 2018 Sep 30;2018:7897346. doi: 10.1155/2018/7897346. eCollection 2018.
3
[CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].[细胞周期蛋白依赖性激酶1、细胞周期蛋白B1和NDC80与乙型肝炎病毒相关肝细胞癌的预后和进展相关:一项生物信息学分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Oct 20;41(10):1509-1518. doi: 10.12122/j.issn.1673-4254.2021.10.09.
4
CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.CDK1、CCNB1 和 CCNB2 是肝癌的预后生物标志物,并与免疫浸润相关。
Med Sci Monit. 2020 Aug 31;26:e925289. doi: 10.12659/MSM.925289.
5
CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.CDK1、CCNB1、CDC20、BUB1、MAD2L1、MCM3、BUB1B、MCM2 和 RFC4 可能是使用综合生物信息学分析治疗肝细胞癌的潜在治疗靶点。
Biomed Res Int. 2019 Oct 13;2019:1245072. doi: 10.1155/2019/1245072. eCollection 2019.
6
CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.CDK20 可作为预测肝细胞癌患者预后的潜在基于生物标志物的风险评分系统。
Oxid Med Cell Longev. 2022 Sep 19;2022:8421813. doi: 10.1155/2022/8421813. eCollection 2022.
7
System biology analysis of cell cycle pathway involved in hepatocellular carcinoma.肝细胞癌中细胞周期通路的系统生物学分析
Front Biosci (Schol Ed). 2010 Jun 1;2(3):1127-44. doi: 10.2741/s122.
8
FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.FOXM1 通过转录激活 CCNB1 促进人肝癌细胞的增殖。
Biochem Biophys Res Commun. 2018 Jun 12;500(4):924-929. doi: 10.1016/j.bbrc.2018.04.201. Epub 2018 Apr 30.
9
Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.基于基因表达综合数据库的生物信息学分析提示 TAF7/CCNB1、TAF7/CCNA2 和 GTF2E2/CDC20 通路与胶质母细胞瘤的发生发展和预后相关。
World Neurosurg. 2020 Jun;138:e492-e514. doi: 10.1016/j.wneu.2020.02.159. Epub 2020 Mar 5.
10
The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.CCT6A、CDC20、CCNB1 和 PLK1 的表达相互关系及其在甲状腺乳头状癌预后预测中的临床价值。
J Clin Lab Anal. 2022 Sep;36(9):e24609. doi: 10.1002/jcla.24609. Epub 2022 Jul 15.

引用本文的文献

1
SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.SNRPB/CCNB1轴通过增强脂质代谢重编程促进肝细胞癌进展和顺铂耐药。
J Exp Clin Cancer Res. 2025 Jul 18;44(1):211. doi: 10.1186/s13046-025-03463-y.
2
Exploring the potential function of high expression of in regulating ubiquitination in hepatocellular carcinoma.探索[具体物质]高表达在调节肝细胞癌泛素化中的潜在功能。 (注:原文中“in regulating ubiquitination”前缺少具体物质,这里假设用[具体物质]替代)
World J Gastrointest Oncol. 2025 May 15;17(5):103594. doi: 10.4251/wjgo.v17.i5.103594.
3
In Silico Network Toxicology, Molecular Docking, and Multi-Level Bioinformatics Reveal Methyl Eugenol-Induced Hepatocellular Carcinoma Mechanisms in Humans.计算机网络毒理学、分子对接和多层次生物信息学揭示了甲基丁香酚诱导人类肝细胞癌的机制。
Cancer Med. 2025 May;14(10):e70768. doi: 10.1002/cam4.70768.
4
Multiple-omics analysis of aggrephagy-related cellular patterns and development of an aggrephagy-related signature for hepatocellular carcinoma.自噬相关细胞模式的多组学分析及肝细胞癌自噬相关特征的建立
World J Surg Oncol. 2025 Apr 30;23(1):175. doi: 10.1186/s12957-025-03816-z.
5
Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation study.CCNB1作为肝细胞癌细胞衰老生物标志物的鉴定:一项生物信息学与实验验证研究
Discov Oncol. 2025 Mar 24;16(1):384. doi: 10.1007/s12672-025-02182-2.
6
An Integrated Framework to Identify Prognostic Biomarkers and Novel Therapeutic Targets in Hepatocellular Carcinoma-Based Disabilities.一种基于肝细胞癌相关残疾来识别预后生物标志物和新型治疗靶点的综合框架。
Biology (Basel). 2024 Nov 24;13(12):966. doi: 10.3390/biology13120966.
7
The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO.基于来自基因表达综合数据库(GEO)的转录组分析的人类肝细胞癌中的miRNA-mRNA调控网络
Cancer Rep (Hoboken). 2025 Jan;8(1):e70098. doi: 10.1002/cnr2.70098.
8
Construction and validation of cell cycle-related prognostic genetic model for glioblastoma.构建和验证胶质母细胞瘤细胞周期相关的预后遗传模型。
Medicine (Baltimore). 2024 Oct 4;103(40):e39205. doi: 10.1097/MD.0000000000039205.
9
A Gluconeogenesis-Related Genes Model for Predicting Prognosis, Tumor Microenvironment Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.一种用于预测肝细胞癌预后、肿瘤微环境浸润及药物敏感性的糖异生相关基因模型
J Hepatocell Carcinoma. 2024 Oct 5;11:1907-1926. doi: 10.2147/JHC.S483664. eCollection 2024.
10
Epigenetic identification of LTBP4 as a putative tumor suppressor in breast cancer.鉴定 LTBP4 为乳腺癌潜在抑癌基因的表观遗传学特征。
Epigenomics. 2024;16(14):999-1012. doi: 10.1080/17501911.2024.2388017. Epub 2024 Aug 28.

本文引用的文献

1
Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing expression.黄连汤通过降低[具体表达内容]来抑制肝癌细胞的生长。 (原文中“reducing expression”缺少具体所指,翻译时保留英文以便理解完整意思)
World J Gastroenterol. 2021 Mar 14;27(10):939-958. doi: 10.3748/wjg.v27.i10.939.
2
Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.基于综合生物信息学方法的肝细胞癌潜在关键基因的鉴定与分析
Front Genet. 2021 Mar 9;12:571231. doi: 10.3389/fgene.2021.571231. eCollection 2021.
3
A gene module identification algorithm and its applications to identify gene modules and key genes of hepatocellular carcinoma.基因模块识别算法及其在肝细胞癌基因模块和关键基因识别中的应用。
Sci Rep. 2021 Mar 9;11(1):5517. doi: 10.1038/s41598-021-84837-y.
4
Comprehensive Analysis of Gene Expression Changes and Validation in Hepatocellular Carcinoma.肝细胞癌中基因表达变化的综合分析及验证
Onco Targets Ther. 2021 Feb 15;14:1021-1031. doi: 10.2147/OTT.S294500. eCollection 2021.
5
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.肝细胞癌(HCC):流行病学、病因学和分子分类。
Adv Cancer Res. 2021;149:1-61. doi: 10.1016/bs.acr.2020.10.001. Epub 2020 Nov 28.
6
p97 and p47 function in membrane tethering in cooperation with FTCD during mitotic Golgi reassembly.p97 和 p47 在有丝分裂期间与 FTCD 共同作用于高尔基体重装配过程中的膜连接。
EMBO J. 2021 May 3;40(9):e105853. doi: 10.15252/embj.2020105853. Epub 2021 Feb 8.
7
Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC).增强的DNA修复途径与肝细胞癌(HCC)的细胞增殖及较差的生存率相关。
Cancers (Basel). 2021 Jan 17;13(2):323. doi: 10.3390/cancers13020323.
8
Cyclin A2 localises in the cytoplasm at the S/G2 transition to activate PLK1.细胞周期蛋白 A2 在 S/G2 转换时定位于细胞质中,以激活 PLK1。
Life Sci Alliance. 2021 Jan 5;4(3). doi: 10.26508/lsa.202000980. Print 2021 Mar.
9
PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis.PLK1诱导染色体不稳定并绕过细胞周期检查点以驱动肿瘤发生。
Cancer Res. 2021 Mar 1;81(5):1293-1307. doi: 10.1158/0008-5472.CAN-20-1377. Epub 2020 Dec 29.
10
CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1.CCNB1通过FOXM1调控加速宫颈鳞状细胞癌进展。
Onco Targets Ther. 2020 Dec 1;13:12383-12395. doi: 10.2147/OTT.S279951. eCollection 2020.

促进肝癌的发展,通过介导细胞周期中的 DNA 复制。

promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle.

机构信息

Research Department, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

Department of Radiotherapy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

出版信息

Exp Biol Med (Maywood). 2022 Mar;247(5):395-408. doi: 10.1177/15353702211049149. Epub 2021 Nov 7.

DOI:10.1177/15353702211049149
PMID:34743578
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8919315/
Abstract

In our studies, cyclin B1 () mRNA and protein were overexpressed in hepatocellular carcinoma (HCC) tissues compared with non-HCC tissues. Moreover, was overexpressed in the serum of HCC patients. The expression of was associated with several crucial clinicopathologic characteristics, and the HCC patients with overexpressed had worse overall survival outcomes. In the screening of interactional genes, a total of 266 upregulated co-expression genes, which were positively associated with , were selected from the datasets, and 67 downregulated co-expression genes, which were negatively associated with , were identified. The key genes might be functionally enriched in DNA replication and the cell cycle pathways. , , , and were selected for further research because they were highly connected in the protein-protein interaction networks. Upregulated , , and and downregulated might result in undesirable overall survival outcomes for HCC patients. The univariate Cox analysis results showed that and might be two independent risk factors, while might be protective in HCC. Therefore, may participate in the cell cycle of HCC by regulating DNA replication, and may provide a direction for the diagnosis of early-stage HCC and targeted HCC therapy.

摘要

在我们的研究中,与非 HCC 组织相比,肝癌 (HCC) 组织中 cyclin B1 () mRNA 和蛋白表达过度。此外,在 HCC 患者的血清中也过度表达了。的表达与多个关键的临床病理特征相关,并且表达过度的 HCC 患者的总生存结局更差。在相互作用基因的筛选中,从数据集中共选择了 266 个与 正相关的上调共表达基因,鉴定了 67 个与 负相关的下调共表达基因。关键基因可能在 DNA 复制和细胞周期途径中具有功能富集。因为它们在蛋白质-蛋白质相互作用网络中高度连接,所以选择 、 、 和 进行进一步研究。上调的 和 以及下调的 可能导致 HCC 患者的总生存结果不佳。单因素 Cox 分析结果表明 和 可能是两个独立的危险因素,而 可能在 HCC 中具有保护作用。因此,可能通过调节 DNA 复制参与 HCC 的细胞周期,而 可能为早期 HCC 的诊断和 HCC 的靶向治疗提供方向。